Drugs for life : how pharmaceutical companies define our health
著者
書誌事項
Drugs for life : how pharmaceutical companies define our health
（Experimental futures : technological lives, scientific arts, anthropological voices）
Duke University Press, c2012
- : pbk
並立書誌 全1件
大学図書館所蔵 件 / 全9件
-
該当する所蔵館はありません
- すべての絞り込み条件を解除する
注記
Includes bibliographical references and index
内容説明・目次
内容説明
Every year the average number of prescriptions purchased by Americans increases, as do healthcare expenditures, which are projected to reach one-fifth of the U.S. gross domestic product by 2020. In Drugs for Life, Joseph Dumit considers how our burgeoning consumption of medicine and cost of healthcare not only came to be, but also came to be taken for granted. For several years, Dumit attended pharmaceutical industry conferences; spoke with marketers, researchers, doctors, and patients; and surveyed the industry's literature regarding strategies to expand markets for prescription drugs. He concluded that underlying the continual growth in medications, disease categories, costs, and insecurity is a relatively new perception of ourselves as inherently ill and in need of chronic treatment. This perception is based on clinical trials that we have largely outsourced to pharmaceutical companies. Those companies in turn see clinical trials as investments and measure the value of those investments by the size of the market and profits that they will create. They only ask questions for which the answer is more medicine. Drugs for Life challenges our understanding of health, risks, facts, and clinical trials, the very concepts used by pharmaceutical companies to grow markets to the point where almost no one can imagine a life without prescription drugs.
目次
Acknowledgments ix
List of Illustrations xi
Introduction 1
1. Responding to Facts 27
2. Pharmaceutical Witnessing and Direct-to-Consumer Advertising 55
3. Having to Grow Medicine 87
4. Mass Health: Illness Is a Line You Cross 105
5. Moving the Lines: Deciding on Thresholds 135
6. Knowing Your Numbers: Pharmaceutical Lifestyles 181
Conclusion. Living in a World of Surplus Health: Frequently Asked Questions 197
Notes 219
References 239
Index 257
「Nielsen BookData」 より
